Newsroom

Sorted by: Latest

-

Riassunto: La pulsossimetria Masimo SET® ha dato risultati accurati nei neonati ricoverati in ospedale di tutte le carnagioni nel più ampio studio prospettico condotto in condizioni reali

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) oggi ha annunciato i risultati di uno studio di valutazione della precisione della pulsossimetria Masimo SET® nei neonati in condizioni critiche, dimostrando una distorsione statistica complessiva inferiore all'1%. È importante notare che non ci sono state discrepanze clinicamente significative associate al pigmento cutaneo né casi di ipossiemia occulta nei pazienti di etnia afroamericana o ispanica, e nel complesso si è verificato solo un...
-

Samenvatting: Masimo SET® pulsoximetrie nauwkeurig uitgevoerd bij gehospitaliseerde pasgeborenen van alle huidskleuren in de grootste prospectieve studie in de echte wereld ooit

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) maakte vandaag de bevindingen bekend van een studie ter beoordeling van de nauwkeurigheid van Masimo SET® pulsoximetrie bij kritiek zieke pasgeborenen en vertoonde minder dan 1% algehele statistische vertekening. Belangrijk is dat er geen huidpigmentatiegerelateerde discrepanties van enige klinische betekenis en geen verborgen hypoxemische gebeurtenissen waren onder patiënten van zwarte of Spaanse afkomst, en dit bij slechts één Kaukasische...
-

A oximetria de pulso Masimo SET® apresentou resultados precisos em recém-nascidos hospitalizados de todos os tons de pele no maior estudo prospectivo já realizado em condições reais

IRVINE, Califórnia--(BUSINESS WIRE)--A Masimo (NASDAQ: MASI) anunciou hoje os resultados de um estudo que avaliou a precisão da oximetria de pulso Masimo SET® em recém-nascidos em estado crítico, demonstrando um viés estatístico geral inferior a 1%. É importante destacar que não foram observadas discrepâncias clinicamente significativas relacionadas à pigmentação da pele nem eventos hipoxêmicos ocultos entre pacientes negros ou hispânicos; apenas um paciente caucasiano apresentou tais eventos....
-

Pershing Square Announces Pricing of the Combined IPO of Pershing Square USA and Pershing Square Inc.

NEW YORK--(BUSINESS WIRE)--Pershing Square USA, Ltd. (“PSUS”), an investment company managed by Pershing Square Capital Management, L.P. (“PSCM”), and Pershing Square Inc. (“PSI”), the parent company of PSCM, today announced the pricing of the combined initial public offering (the “PSUS IPO”) of the common shares of beneficial interest of PSUS (the “PSUS Shares”) and the initial public offering (the “PSI IPO”, and together with the PSUS IPO, the “Combined IPO”) of the common stock of PSI (the “...
-

Black Hat Asia 2026 Unveils Key Insights on AI Security and Cloud Infrastructure as APAC Organizations Strengthen Cyber Defenses

SINGAPORE--(BUSINESS WIRE)--Black Hat, the cybersecurity industry’s most established and in-depth security event series, today announced the successful completion of the in-person component of Black Hat Asia 2026 at Marina Bay Sands Expo & Convention Centre in Singapore. The event brought together security professionals from across the Asia-Pacific region and beyond, delivering actionable intelligence on autonomous cyber threats, fragmented data protection frameworks, and the defensive stra...
-

Geographer and Rare Earths Thought Leader Dr. Julie Klinger Shares Insights on Impact Podcast with John Shegerian

LOS ANGELES--(BUSINESS WIRE)--Geographer and Associate Professor in the Nelson Institute for Environmental Studies at the University of Wisconsin, Madison, Julie Michelle Klinger, Ph.D., one of the leading experts on the rare earth supply chain, is a featured guest this week on the Impact Podcast with John Shegerian to share insights on her research and the current state of rare earth and energy supply security. The Webby Award honored podcast is hosted by John Shegerian, Co-Founder, Chairman a...
-

TrialClinIQ Raises $150K from Caduceus Capital, Joins LAUNCH Accelerator, and Opens $1.5M Round to Transform Clinical Trial Access

HOUSTON--(BUSINESS WIRE)--TrialClinIQ, an AI-powered clinical trial recruitment platform based in Houston, Texas advancing health equity, today announced a $150K pre-seed investment from Caduceus Capital Partners and its selection into the Caduceus LAUNCH digital health accelerator. The company has also opened a $1.5M round to accelerate growth. Founded by board-certified neurologist and clinical researcher Jontel Pierce, MD, TrialClinIQ is rethinking how patients are matched to clinical trials...
-

Britain’s ‘unsung heroes’: Taxi drivers hailed as lifeline for millions – but nearly half say they don’t get the credit they deserve

FORMBY, United Kingdom--(BUSINESS WIRE)--Britain’s ‘unsung heroes’: Survey reveals taxi drivers hailed as lifeline for millions – but nearly half say they don’t get the credit they deserve...
-

Samsung Bioepis and ATLATL Sign Memorandum of Understanding (MoU) to Accelerate Early-Stage Biotech Innovation in Asia-Pacific

INCHEON, Korea & SHANGHAI--(BUSINESS WIRE)--Samsung Bioepis Co., Ltd. and ATLATL Innovation Center (hereinafter referred to as "ATLATL"), global innovation platform for life science research and development, today announced that the companies have entered into a Memorandum of Understanding (MoU) on an open innovation program to accelerate early-stage biotech innovation in Asia-Pacific. Through this partnership, Samsung Bioepis aims to leverage ATLATL’s innovative R&D network and expertise i...
-

SCX Brings Sovereign AI to Equinix’s AI Ecosystem and Confirms National Expansion with SambaNova SN50

SYDNEY--(BUSINESS WIRE)--SouthernCrossAI (SCX), Australia's full-stack sovereign AI infrastructure company, today announced it is now providing sovereign AI inferencing capacity to the Equinix Fabric AI ecosystem, making its ASIC-powered inference nodes discoverable and accessible to enterprises, government agencies, and developers across the Equinix ecosystem. Alongside this milestone, SCX confirmed that its national infrastructure expansion will be powered by SambaNova's next-generation SN50...